RVMD
Revolution MedicinesยทNASDAQ
--
--(--)
--
--(--)
RVMD Profile
Revolution Medicines, Inc.
A clinical-stage oncology company that developing novel targeted therapies for RAS-addicted cancers
700 Saginaw Drive, Redwood City, California 94063
--
Revolution Medicines, Inc., founded in October 2014, is a Delaware corporation. The company is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit cutting-edge targets in RAS addictive cancer. The company has advanced structure-based drug discovery capabilities, based on deep chemical biology and cancer pharmacology knowledge and innovative proprietary technology, capable of creating small molecules suitable for unconventional binding sites. The company's understanding of cancer's genetic drivers and adaptive resistance mechanisms, coupled with strong drug discovery and pharmacochemistry capabilities, has guided the establishment of a deep pipeline for key signaling nodes in the RAS pathway and related pathways.
